Today Breast cancer is the most common cancer among women and responsible for 25% of all cancers in women. Telomerase is an appropriate anticancer therapeutic target because it is present in over 90% of human cancers, including more than 95% of breast cancers, while in most somatic cells it is not detectable. The hTERT protein is a component of the rate-limiting telomerase complex, so the expression of the hTERT gene inside the cells is essential for the activation of telomerase. miRNAs are a bunch of small, non-coding RNAs with a length of 25-19 nucleotides that play a key role as gene expression regulators.Some genetic susceptibility may play a minor role in most cases. Overall, however, genetics is believed to be the primary cause of 5–10% of all cases.Women whose mother was diagnosed before 50 have an increased risk of 1.7 and those whose mother was diagnosed at age 50 or after has an increased risk of 1.4. In those with zero, one or two affected relatives, the risk of breast cancer before the age of 80 is 7.8%, 13.3%, and 21.1% with a subsequent mortality from the disease of 2.3%, 4.2%, and 7.6% respectively.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Manoush Tohidi Rad,Mahya Fatahi,Shahin Asadi Molecular Geneticist, Studied Molecular Biology at Tabriz and Ahar Islamic Azad University Sciences.B.S,Molecular and Cellular Biology-Genetics,MS.c Molecular Biology and Genetics Director of the Division of Medical Genetics and Molecular Research in Iran.
Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne
Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Today Breast cancer is the most common cancer among women and responsible for 25% of all cancers in women. Telomerase is an appropriate anticancer therapeutic target because it is present in over 90% of human cancers, including more than 95% of breast cancers, while in most somatic cells it is not detectable. The hTERT protein is a component of the rate-limiting telomerase complex, so the expression of the hTERT gene inside the cells is essential for the activation of telomerase. miRNAs are a bunch of small, non-coding RNAs with a length of 25-19 nucleotides that play a key role as gene expression regulators.Some genetic susceptibility may play a minor role in most cases. Overall, however, genetics is believed to be the primary cause of 5-10% of all cases.Women whose mother was diagnosed before 50 have an increased risk of 1.7 and those whose mother was diagnosed at age 50 or after has an increased risk of 1.4. In those with zero, one or two affected relatives, the risk of breast cancer before the age of 80 is 7.8%, 13.3%, and 21.1% with a subsequent mortality from the disease of 2.3%, 4.2%, and 7.6% respectively. 52 pp. Englisch. N° de réf. du vendeur 9786134912051
Quantité disponible : 2 disponible(s)
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
Taschenbuch. Etat : Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Today Breast cancer is the most common cancer among women and responsible for 25% of all cancers in women. Telomerase is an appropriate anticancer therapeutic target because it is present in over 90% of human cancers, including more than 95% of breast cancers, while in most somatic cells it is not detectable. The hTERT protein is a component of the rate-limiting telomerase complex, so the expression of the hTERT gene inside the cells is essential for the activation of telomerase. miRNAs are a bunch of small, non-coding RNAs with a length of 25-19 nucleotides that play a key role as gene expression regulators.Some genetic susceptibility may play a minor role in most cases. Overall, however, genetics is believed to be the primary cause of 5-10% of all cases.Women whose mother was diagnosed before 50 have an increased risk of 1.7 and those whose mother was diagnosed at age 50 or after has an increased risk of 1.4. In those with zero, one or two affected relatives, the risk of breast cancer before the age of 80 is 7.8%, 13.3%, and 21.1% with a subsequent mortality from the disease of 2.3%, 4.2%, and 7.6% respectively. N° de réf. du vendeur 9786134912051
Quantité disponible : 1 disponible(s)
Vendeur : moluna, Greven, Allemagne
Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Tohidi Rad ManoushManoush Tohidi Rad,Mahya Fatahi,Shahin Asadi Molecular Geneticist, Studied Molecular Biology at Tabriz and Ahar Islamic Azad University Sciences.B.S,Molecular and Cellular Biology-Genetics,MS.c Molecular Biology and. N° de réf. du vendeur 385843809
Quantité disponible : Plus de 20 disponibles
Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagne
Taschenbuch. Etat : Neu. This item is printed on demand - Print on Demand Titel. Neuware -Today Breast cancer is the most common cancer among women and responsible for 25% of all cancers in women. Telomerase is an appropriate anticancer therapeutic target because it is present in over 90% of human cancers, including more than 95% of breast cancers, while in most somatic cells it is not detectable. The hTERT protein is a component of the rate-limiting telomerase complex, so the expression of the hTERT gene inside the cells is essential for the activation of telomerase. miRNAs are a bunch of small, non-coding RNAs with a length of 25-19 nucleotides that play a key role as gene expression regulators.Some genetic susceptibility may play a minor role in most cases. Overall, however, genetics is believed to be the primary cause of 5¿10% of all cases.Women whose mother was diagnosed before 50 have an increased risk of 1.7 and those whose mother was diagnosed at age 50 or after has an increased risk of 1.4. In those with zero, one or two affected relatives, the risk of breast cancer before the age of 80 is 7.8%, 13.3%, and 21.1% with a subsequent mortality from the disease of 2.3%, 4.2%, and 7.6% respectively.Books on Demand GmbH, Überseering 33, 22297 Hamburg 52 pp. Englisch. N° de réf. du vendeur 9786134912051
Quantité disponible : 1 disponible(s)
Vendeur : preigu, Osnabrück, Allemagne
Taschenbuch. Etat : Neu. The Sins of Genes | The study of expression of miRNA-133 and miRNA-431b in Breast Cancer | Manoush Tohidi Rad (u. a.) | Taschenbuch | 52 S. | Englisch | 2018 | LAP Lambert Academic Publishing | EAN 9786134912051 | Verantwortliche Person für die EU: BoD - Books on Demand, In de Tarpen 42, 22848 Norderstedt, info[at]bod[dot]de | Anbieter: preigu. N° de réf. du vendeur 110988383
Quantité disponible : 5 disponible(s)